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Background 
Global crustacean aquaculture is dominated by penaeid (shrimp/prawn) farming, the annual production of which far 
exceeds that of wild capture fisheries, with over 70% of the shrimp produced globally being sourced from 
aquaculture. Consequently, the commercial culture of penaeid shrimp is an extremely large global industry, worth 
many billions of dollars annually. The Pacific white shrimp, Litopenaeus vannamei is currently the most 
commercially-cultured crustacean species worldwide. It surpassed the Giant tiger prawn, Penaeus monodon, as the 
primary species of shrimp aquaculture in 2004,  due mainly to the difficulty of breeding and the greater susceptibility 
to disease of the latter (http://fao.org/2009). Global aquaculture production of L. vannamei in 2007 was estimated 
as ca. 2,300,000 tonnes (http://fao.org/2009). This investigation will determine, using in vitro methods, the potential 
of and degree to which the Xyrex
®
 products Prawnfresh™ and Prawnfresh+™ inhibit the growth of Vibrio harveyi 
(NCIMB 1280) and Vibrio campbellii (NCIMB 1894). Both of these bacterial species are known causative agents of 
luminescent Vibriosis, widely regarded to be the most significant bacterial disease affecting cultured juvenile and 
adult L. vannamei (Jayasree et al., 2006; Soto-Rodríguez et al., 2006).  
 
Project aims 
 To quantify the effectiveness of the Xyrex® products Prawnfresh™ and Prawnfresh+™ in interfering with or 
inhibiting the growth of the penaeid bacterial pathogens Vibrio harveyi (NCIMB 1280) and Vibrio campbellii 
(NCIMB 1894), and thereby their inferred activity against Vibrio spp. in general. 
 
 Secondly, to ascertain whether dosage (concentration) and culture temperature are significant variables 
influencing any antibacterial activity of Prawnfresh™ and Prawnfresh+™. 
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Project deliverables 
A scientific report provided to Xyrex Ltd. that describes the results obtained and draws conclusions about: 
 The effectiveness of Xyrex® products Prawnfresh™ and Prawnfresh+™ in interfering with or inhibiting the 
growth of penaeid bacterial pathogens Vibrio harveyi (NCIMB 1280) and Vibrio campbellii (NCIMB 1894), and 
thereby their inferred activity against Vibrio spp. in general.  
 The most effective dosages (concentrations) of Prawnfresh™ and Prawnfresh+™ and culture temperature for 
suppressing bacterial activity. 
 
Materials and Methods 
An antibacterial disc assay utilising the combined and modified methodologies of Bauer et al. (1966) and Pilet et al. 
(1995) was used to determine the effectiveness of Prawnfresh™ and Prawnfresh+™ in inhibiting the growth of V. 
harveyi (NCIMB 1280) and V. campbellii (NCIMB 1894). Twenty five millilitres of V. harveyi culture, previously grown 
up in TSB broth (plus 2% NaCl) for 18 h at 25oC, was aseptically mixed with 325 ml of molten TSA (plus 2% NaCl) at 
40oC. Sufficient TSA powder and NaCl was used for a 350 ml final volume. The resulting agar-pathogen suspension 
was then aseptically dispensed into twenty 90 mm Petri dishes. This process was then repeated for V. campbellii.  
Three concentrations of Prawnfresh™ and Prawnfresh+™ solutions, at 1, 2 and 4 parts per thousand (ppt), were 
tested using standard disc antibiotic susceptibility assay methods, as originally defined by Bauer et al. (1966). Test 
solutions were prepared as per the manufacturer’s instructions and tested alongside a negative control (sterile 3.2% 
NaCl solution).   
Autoclaved, 13 mm diameter discs of Whatman No. 17 antibiotic assay chromatography paper were prepared by 
pipetting 100 μl of test solution onto their surface, before being left to rest for 10 min to allow the solution time to 
infuse. Forty five discs were prepared for each solution. Four discs (representing the three test solutions plus the 
control) were positioned equidistantly, using flamed forceps, on each pathogen/agar plate. Five replicates plates (of 
each pathogen) were incubated at one of three temperatures (20oC, 25oC or 30oC) to investigate the ability of 
Prawnfresh™ and Prawnfresh+™ to inhibit pathogen growth over a range of transport/processing conditions. 
Each plate was then examined for evidence of growth interference/inhibition after 24 h and 48 h incubation. Such 
interference/inhibition is typically characterised by a region of reduced colony growth (clear agar) around the test 
disc. Any zone, or ‘halo’, of such pathogen growth interference or inhibition was subsequently recorded using digital 
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callipers (zone diameter in mm, including the 13 mm disc). The effective zone radius was then determined by 
subtracting the disc diameter (thirteen) and halving the subsequent value.  
 
Results & Discussion 
Only the results for the Prawnfresh™ test solutions are displayed as at no time did Prawnfresh+™ exhibit any 
detectable antagonistic or antibacterial activity against either V. harveyi (NCIMB 1280) or V. campbellii (NCIMB 
1894).  
It should be noted that the term growth interference will be used in preference to growth inhibition as the former is 
more accurate in describing the observed effects of Prawnfresh™ on the pathogens. The presence of bacterial 
growth (i.e. colonies) within the zone/halo surrounding the majority of discs precludes the effect being described as 
inhibition. These colonies, however, appeared reduced in terms of both their number and size in comparison with 
the area surrounding the control disc, although the observed effect was considerably less in the case of V. campbellii 
(Figures 2 & 3).  
Although no measurements were taken, surviving plates (i.e. those not exhibiting excessive desiccation) were 
examined also at 96 h post inoculation. As at 24 and 48 hours the Prawnfresh+™ plates continued to exhibit no 
antagonistic activity against either pathogen. With regard to the Prawnfresh™ test plates, all V. campbellii inoculated 
plates were fully overgrown (not shown), i.e. by 96h the pathogen had overcome the antagonistic effects of the 
product. Halos of growth interference were still apparent on all V. harveyi inoculated plates for all temperatures and 
concentrations of the product; however, the zones surrounding the 1ppt treatment discs did appear to have 
diminished slightly, both in their size and effectiveness (Figures 2ii & 2iii).  
A clear positive correlation is apparent between the concentration of the Prawnfresh™ solution used and the radial 
width of the halo of antagonism (zone of growth interference) (Figure 1). Thus the most effective dosage tested for 
interfering with the growth of both pathogens, over a 20-30oC temperature range, was the 4ppt solution (Figure 1). 
Furthermore, standard deviation values indicate that incubation temperature does not appear to be a significant 
variable in the effectiveness of Prawnfresh™. Also in the case of V. harveyi no significant variation in zone width was 
apparent between the 24 and 48 hour values at both 25oC and 30oC (Figure 1). In the 96 hour observations the V. 
harveyi colonies present within the zones showed a slight increase in size; however, no variation was apparent in 
zone width and most significantly no new colonies were detectable (Figure 2iii).  
The effectiveness of Prawnfresh™ in interfering with the growth of V. campbellii was markedly less than that 
observed for V. harveyi (Figure 1). Unlike V. harveyi, V. campbellii appeared to largely overcome the antagonistic 
effects of Prawnfresh™ at the lower concentrations of 1 & 2ppt within 48 hours, and within 96 hours for the 4ppt 
treatment (Figure 1). It is not unusual to observe variation in the effectiveness of antimicrobials between bacterial 
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strains and unless complete resistance is observed this could likely be overcome through the utilisation of an 
increased dose. However, this approach is not recommended when dealing with live animals, as excessive use may 
result in the creation of strains resistance to the agent’s effects, as is the case with the prophylactic use of antibiotics 
in aquaculture (Li et al., 1999; Laganà et al., 2011). However, in the present case the agent in question, Prawnfresh™, 
is designed for use on harvested and therefore dead shrimp destined for human consumption. Consequently the 
likelihood of producing such resistant bacteria, and for them to become established in the wider microbial flora, is 
remote. 
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Figure 1. Mean radial width, in mm, of the growth interference zone/halo surrounding discs infused with solutions of 0, 1, 2 & 4 
parts per thousand of Prawnfresh™, on Vibrio harveyi and Vibrio campbellii plates after (i) 24 hours at 30
o
C, (ii) 48 hours at 30
 o
C, 
(iii) 24 hours at 25
 o
C, (iv) 48 hours at 25
 o
C, (v) 24 hours at 20
 o
C and (vi) 48 hours at 20
 o
C. Data displayed as mean values +/- 
S.D. N=5 in each case. 
(i) (ii) 
(iii) (iv) 
(v) (vi) 
(i) (ii) 
(iii) (iv) 
(v) (vi) 
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Figure 2. V. harveyi inoculated replicate plate 1 incubated at 30
o
C; (i) after 24 hours, (ii) after 48 hours with zones/halos of 
interference circled & (iii) after 96 hours. (‘C’ denotes control solution (3.2% NaCl); ‘1’ denotes 1ppt Prawnfresh™ solution; ‘2’ 
denotes 2ppt Prawnfresh™ solution and ‘4’ denotes 4ppt Prawnfresh™ solution).  
 
 
Figure 3. V. campbellii inoculated plates incubated at 30
o
C; (i) after 24 hours & (ii) after 48 hours with zone/halo of interference 
circled. (‘C’ denotes control solution (3.2% NaCl); ‘1’ denotes 1ppt Prawnfresh™ solution; ‘2’ denotes 2ppt Prawnfresh™ solution 
and ‘4’ denotes 4ppt Prawnfresh™ solution).  
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Conclusions 
 Prawnfresh™ displays the capacity to retard/interfere with the growth of both bacterial pathogens tested, V. 
campbellii and V. harveyii, but was significantly more effective in the case of V. harveyi. 
 The greater the concentration of the Prawnfresh™ solution used the more effective it was in 
retarding/interfering with growth of V. harveyi (NCIMB 1280) and V. campbellii (NCIMB 1894). This will also 
most likely be the case for related species of Vibrio bacteria. 
 Temperature, and also in the case of V. harveyi length of incubation period, do not appear to be significant 
variables in the effectiveness of Prawnfresh™ in interfering with the growth of the pathogens. 
 The finding of a complete lack of any antagonistic activity by the test solutions of Prawnfresh+™ strongly 
indicates that components that are present in Prawnfresh™ but absent in Prawnfresh+™ are responsible for 
the antibacterial effects observed. 
 Further to the above, the antagonistic effects on Vibrio species by Prawnfresh™ would likely be enhanced by 
increasing the concentration of these components. This would have a secondary benefit in that the overall 
recommended dosage of Prawnfresh™ (1ppt) could remain unaltered while providing increased bacterial 
antagonism. 
 
Recommendations 
 Further in vitro assessment to definitively isolate the active ingredient/ingredients responsible for the Vibrio 
growth interference observed. 
 In vivo testing, to confirm the functional capacity of  Prawnfresh™ to interfere with bacterial and particularly 
Vibrio growth. This would involve the assessment of the external colony forming units present on recently 
harvested shrimp (treated versus untreated). 
 Although not the principal function of Prawnfresh™ its ability to interfere with the growth of two of the 
primary causative agents of luminescent Vibriosis could provide a useful additional marketing tool in 
demonstrating its superiority over other products in the marketplace, such as sodium metabisulphite. 
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